HyaRegenŽ Gel
Prevention of Adhesion
- Meticulous and careful surgical technique
- Prophylactic application of adhesion barrier
ESGE Consensus guideline: Using adhesion reduction agents are an important part of adhesion reduction strategy; achieving full prevention de novo and reformed adhesions (De Wilde RL et al: Arch Gynecol Obstet. 2014; 290:581)
Patient Benefits
- Reduced adhesions
- Enhanced pregnancy rate
- Limited bowel obstruction
- Improved quality of life
- Prevented re-admission
Unique features and functions
- Easy to use via endoscopy or open surgery
- Absorbable up to 14 days to provide complete coverage during the critical period of tissue repair
- Preventing adhesion in surgical intervention area and remote locations in entire abdominopelvic cavity
- Proven efficacious and safety from randomised clinical trial
HyaRegen Gel: unique material features
- Adequate viscosity and hydrophilic property: creation of moist environment facilitating scar free tissue regeneration
- Controlled degradation profile: physical barrier during the tissue healing critical period to prevent adhesion and scar formation
- Terminal sterilisation: maximized safety after application
- Degradable and completely bioresorbable: avoid secondary damage to the regenerated tissue
- Easy to use: no mixing required, flexible delivery cannula to facilitate application and to reach the desired location
- Non-animal-sourced hyaluronic acid raw material used for production: avoid potential reactions to xenogeneic proteins
- Optimized and controlled degradation of the Gel ensures complete coverage and protection to the organs
HyaRegen Gel degrades in abdominopelvic cavity for up to 14 days
- Covers traumatised organ surfaces during the critical period of tissue repair processes
- Provides effective barrier to separate the organs
Video:
HyaRegen Gel used in Laparoscopic Total Hysterotomy
HyaRegen Gel used in Myomectomy and Fallopian Tube Adhesiolysis
Want to know more?
Call us on 01884 266377